However, CHD4 mutations found in BC tumors have revealed defects in different structural domains that could give rise to diverse effects such as lower ATPase activity, decreased nucleosome binding, inefficient coupling of ATPase and remodeling activities, and altered nucleosome positioning (e.g. R877Q/W, R975H, R1162W, R572*). The gene discussed is CHD4; the disease is breast cancer.